Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
Bone Marrow Transplantation
|
April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)
Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
The Lancet. Haematology
|
February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Tapani Ruutu, et al.
The New England Journal of Medicine
|
December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Haematologica
|
October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Olaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation
Jan Styczynski, Gloria Tridello, Lidia Gil, et al.
Blood
|
May 15, 2008
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán, et al.
Transfusion
|
September 15, 2023
Transfusion-associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow-up. A prospective cohort study
José L Bueno, Ana B Bocanegra, Isabel Sánchez, et al.
Bone Marrow Transplantation
|
August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study
Tapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Bone Marrow Transplantation
|
April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group
Marion Larue, Florent Malard, Ahmed S Alaskar, et al.
Haematologica
|
November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
Bone Marrow Transplantation
|
April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)
Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
The Lancet. Haematology
|
February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Tapani Ruutu, et al.
The New England Journal of Medicine
|
December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Haematologica
|
October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Olaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation
Jan Styczynski, Gloria Tridello, Lidia Gil, et al.
Blood
|
May 15, 2008
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán, et al.
Transfusion
|
September 15, 2023
Transfusion-associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow-up. A prospective cohort study
José L Bueno, Ana B Bocanegra, Isabel Sánchez, et al.
Bone Marrow Transplantation
|
August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study
Tapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Bone Marrow Transplantation
|
April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group
Marion Larue, Florent Malard, Ahmed S Alaskar, et al.
Haematologica
|
November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Page
of 12